Journal
AMERICAN JOURNAL OF MEDICINE
Volume 134, Issue 6, Pages 727-734Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2021.01.015
Keywords
Cirrhosis; Immune dysfunction; Infections
Categories
Ask authors/readers for more resources
Cirrhosis is a significant contributor to morbidity and mortality worldwide, with infections impacting quality of life. Understanding immune dysfunction and managing infections in cirrhosis has become more nuanced with increasing rates of drug-resistant organisms. This review discusses cirrhosis-associated immune deficiency, common infections, and techniques for prevention and treatment in high-risk populations.
Cirrhosis contributes significantly to morbidity and mortality worldwide. Infections in patients with cirrhosis are common and significantly impact health-related quality of life. As our understanding of immune dysfunction associated with cirrhosis grows and as rates of drug-resistant organisms increase, the management of infections in cirrhosis has become increasingly nuanced. In this review, we discuss the current understanding of cirrhosis-associated immune deficiency, review the most common infections in patients with cirrhosis, and highlight techniques for the general clinician in the prevention and treatment of infections in this high-risk population. (C) 2021 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available